We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




SET Oximetry Detects Apnea-Related Hypoxemia

By HospiMedica staff writers
Posted on 31 May 2001
A study has found that oximetry employing signal extraction technology (SET) can improve the detection of hypoxemia related to obstructive sleep apnea. More...
The study, conducted by researchers at the Robert Debre Hospital in Paris (France), was presented at the annual meeting of the American Thoracic Society in San Francisco (CA, USA).

Low arterial oxygen saturation is an early warning of a significant episode of obstructive sleep apnea (OSA). A large number of hypoxemic episodes and lengthy desaturation during sleep are considered as major indicators of severe OSA. Pulse oximetry is the most common method of measuring hypoxemia but it has been proven unreliable due to patient movement and other types of interference.

In the study, the researchers evaluated the use of SET pulse oximetry with two other oximeters based on different technology for detecting apnea-related hypoxemia. They found that the SET oximetry detected 35% more hypoxemic events than one of these and 65% more events than the other. The researchers blamed this poorer performance on the "freezing” of other technology. In another recent study, involving children, researchers found that an oximeter using other technology missed entire runs of periodic breathing and hypoxemic episodes. SET was developed by Masimo Corp. (Irvine, CA, USA; www.masimo.com) and has been incorporated in the oximetry products of the company and of other firms.



Related Links:
Masimo

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.